Atlas Trials

Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism

Clinical trial NCT01572259 · UNKNOWN

Trial details

NCT number
NCT01572259
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2011-09-01
Primary completion
2016-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.